NASDAQ:SUPN

Supernus Pharmaceuticals Stock Insider Trading

etoro logo Buy SUPN
*Your capital is at risk
$44.63
-0.98 (-2.15%)
At Close: Jul 31, 2026

Supernus Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -46.56. In total, the insiders bought 563.66K and sold 247.69K SUPN shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-46.56
Buy 563.66K shares
Sell 247.69K shares
56% Buy Activity
Moderate Negative Correlation
Buy Signal Low Confidence
Mar 02, 2026

Analysis Breakdown:

  • Signal is highly questionable due to a strongly contradictory negative Insider Power Score of -46.56.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Mar 13, 2026
Buy
Common Stock
J-Other
Khattar Jack A.
President, CEO
CEO / President 12 500
Value: $623.9K
Mar 13, 2026
Sell
Common Stock
S-Sale
Khattar Jack A.
President, CEO
CEO / President 120
Value: $6K
Mar 12, 2026
Sell
Common Stock
S-Sale
Hudson Frederick M.
Director
Director 5 369
Value: $271.7K
Mar 10, 2026
Sell
Common Stock
S-Sale
Horich William Todd
SVP, Commercial Operations
Officer 4 439
Value: $244.1K
Mar 09, 2026
Sell
Common Stock
S-Sale
Horich William Todd
SVP, Commercial Operations
Officer 4 438
Value: $239.7K
Mar 09, 2026
Sell
Common Stock
S-Sale
Mottola Frank
SVP, Chief Tech. Ops. Officer
Officer 1 623
Value: $87.1K
Mar 06, 2026
Buy
Common Stock
M-Exempt
Horich William Todd
SVP, Commercial Operations
Officer 1 125
Value: $60.6K
Mar 06, 2026
Sell
Common Stock
F-InKind
Horich William Todd
SVP, Commercial Operations
Officer 1 216
Value: $66.6K
Mar 06, 2026
Buy
Performance Share Unit
M-Exempt
Horich William Todd
SVP, Commercial Operations
Officer 1 125
Value: $60.6K
Mar 06, 2026
Buy
Common Stock
M-Exempt
Dec Timothy C
Senior Vice-president & CFO
CEO / President 3 000
Value: $161.6K
Mar 06, 2026
Sell
Common Stock
F-InKind
Dec Timothy C
Senior Vice-president & CFO
CEO / President 1 450
Value: $79.4K
Mar 06, 2026
Buy
Common Stock
M-Exempt
Dec Timothy C
Senior Vice-president & CFO
CEO / President 3 000
Value: $161.6K
Mar 06, 2026
Sell
Common Stock
F-InKind
Dec Timothy C
Senior Vice-president & CFO
CEO / President 1 433
Value: $78.4K
Mar 06, 2026
Buy
Performance Share Unit
M-Exempt
Khattar Jack A.
President, CEO
CEO / President 38 640
Value: $2.08M
Mar 06, 2026
Buy
Common Stock
M-Exempt
Mottola Frank
SVP, Chief Tech. Ops. Officer
Officer 3 750
Value: $202.0K
Mar 06, 2026
Sell
Common Stock
F-InKind
Mottola Frank
SVP, Chief Tech. Ops. Officer
Officer 1 793
Value: $98.1K
Mar 06, 2026
Buy
Performance Share Unit
M-Exempt
Mottola Frank
SVP, Chief Tech. Ops. Officer
Officer 3 750
Value: $202.0K
Mar 06, 2026
Sell
Common Stock
F-InKind
Khattar Jack A.
President, CEO
CEO / President 16 574
Value: $907.1K
Mar 06, 2026
Buy
Common Stock
M-Exempt
Khattar Jack A.
President, CEO
CEO / President 38 640
Value: $2.08M
Mar 06, 2026
Buy
Common Stock
M-Exempt
Horich William Todd
SVP, Commercial Operations
Officer 3 750
Value: $202.0K
Mar 06, 2026
Buy
Performance Share Unit
M-Exempt
Dec Timothy C
Senior Vice-president & CFO
CEO / President 3 000
Value: $161.6K
Mar 06, 2026
Buy
Common Stock
M-Exempt
Horich William Todd
SVP, Commercial Operations
Officer 2 625
Value: $141.4K
Mar 06, 2026
Sell
Common Stock
F-InKind
Horich William Todd
SVP, Commercial Operations
Officer 1 718
Value: $94.0K
Mar 06, 2026
Sell
Common Stock
F-InKind
Horich William Todd
SVP, Commercial Operations
Officer 521
Value: $28.5K
Mar 06, 2026
Buy
Director Stock Option (Right to Buy)
M-Exempt
Gemayel Georges
Director
Director 7 905
Value: $200.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SUPERNUS PHARMACEUTICALS
Supernus Pharmaceuticals
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prophylaxis of migraine headache; and Oxtellar XR, an extended release oxcarbazepine for the monotherapy tr...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE